Related Experiment Videos
[Non-Hodgkin's lymphoma and AIDS: histopathologic features]
M Raphael1, M Lamine, I Abd Alsamad
1Département d'Hématologie, Groupe Hospitalier Pitié-Salpêtrière, Paris.
Archives D'Anatomie Et De Cytologie Pathologiques
|January 1, 1992
Summary
HIV-related non-Hodgkin lymphomas, often high-grade tumors in AIDS patients, can be classified using immunophenotypic studies. These studies analyze B-cell markers to differentiate subtypes like Burkitt and immunoblastic lymphomas.
Area of Science:
- Hematology
- Oncology
- Immunology
Context:
- HIV-related non-Hodgkin lymphomas (NHL) affect 5-8% of AIDS patients.
- These are high-grade tumors with variable morphology, complicating classification.
- Immunophenotypic analysis aids in characterizing these aggressive lymphomas.
Purpose:
- To detail the utility of immunophenotypic studies in classifying HIV-related non-Hodgkin lymphomas.
- To compare immunophenotypic findings with morphologic features of Burkitt and immunoblastic types.
- To investigate the origin of Burkitt lymphomas based on B-cell marker expression.
Summary:
- Immunophenotypic studies using B-cell differentiation and activation antigens (e.g., CD10, CD19, CD20) are crucial for characterizing HIV-related NHL.
- Burkitt lymphomas were found to be monoclonal, expressing B-cell markers (CD10, CD19, CD20, CD22, CD38) and surface immunoglobulins (IgM kappa), suggesting a centrofollicular origin.
- Immunoblastic lymphomas showed variable expression of CD10 and CD38, with a high proliferation rate indicated by Ki67 staining.
Impact:
- Provides a clearer understanding of the immunophenotypic profiles of different HIV-related NHL subtypes.
- Supports the hypothesis that Burkitt lymphomas in this context may arise from centrofollicular cells.
- Highlights the importance of immunophenotyping for accurate diagnosis and potentially guiding treatment strategies for AIDS-related lymphomas.